Section 1 of 12

Instant Drug Testing — Introduction

Instant drug testing — also called point-of-collection testing (POCT) or rapid drug testing — gives an on-the-spot screening result in 5 minutes. It's used widely in non-DOT employment, pre-employment, post-accident, and reasonable-suspicion contexts. This module covers everything you need to collect, read, and document an instant test correctly.

What This Module Covers

  • What instant drug testing is and when to use it
  • FUO vs CLIA-Waived — and which applies to YOUR program
  • Device types and how to choose
  • The collection procedure step-by-step
  • Reading results — and the "two lines = negative" rule
  • What to do with a non-negative result
  • Documentation that protects you and the employer

Who This Is For

Non-DOT collectors, HR / safety managers handling onsite testing, and clinic staff who run rapid screening for workplace programs.

Reminder: Instant testing is NOT permitted for DOT-regulated tests. DOT requires laboratory-based testing at SAMHSA-certified labs.
Section 1 of 12
Section 2 of 12

Regulatory Context — FUO vs CLIA-Waived

Instant drug testing is NOT under 49 CFR Part 40. But two regulatory frameworks shape it: FUO (Forensic Use Only) device classification and the CLIA Certificate of Waiver requirement. Knowing which applies — based on the device and the purpose — is the difference between compliant and exposed.

Two Frameworks

  • FUO (Forensic Use Only) — the device is labeled for forensic use only, used to make employment decisions. NOT a medical / clinical test. CLIA does NOT apply to FUO devices for employment purposes.
  • CLIA-Waived — the device is FDA-cleared as a clinical diagnostic. Using it for a clinical decision triggers CLIA Certificate of Waiver requirements.

Which Applies to You?

PurposeDeviceCLIA?
Employment / forensicFUO deviceNo
Clinical / diagnosticCLIA-Waived deviceYes — need Certificate of Waiver
Employment using CLIA deviceCLIA-Waived device, used forensicallyGenerally no — but verify state law

State Variations

Five states regulate workplace drug testing differently:

  • CA · California — state CLIA + federal CLIA
  • MD · Maryland — state CLIA + federal CLIA
  • PA · Pennsylvania — state CLIA + federal CLIA
  • RI · Rhode Island — state CLIA + federal CLIA
  • NY · New York — partial HHS-approved alternative program
  • WA · Washington — full HHS-approved alternative program

Check your state's requirements →

Section 2 of 12
Section 3 of 12

The Collector

A non-DOT instant test collector follows employer policy + the device IFU. No federal qualification certificate exists for non-DOT testing — but training, documentation, and consistency matter for legal defensibility.

Definition

A non-DOT instant test collector is a trained individual who:

  • Verifies donor identity per employer policy
  • Conducts the collection (urine, oral, or other)
  • Operates the device per IFU
  • Reads and documents results
  • Initiates lab confirmation when non-negative

Conflicts of Interest

Same common-sense exclusions as DOT — avoid being the donor's direct supervisor, close relative, or close friend.

Recommended Training

  • Knowledge of the device(s) you'll use
  • Documented IFU walkthroughs
  • 5+ supervised mock collections
  • Annual refresher and result-reading proficiency
  • CLIA Certificate of Waiver training if applicable
Section 3 of 12
Section 4 of 12

The Collection Site

The instant test site needs the same privacy and integrity controls as urine — restroom with bluing, secure work area, and no chance of adulterant access. Most "fail audit" findings happen at the site level.

Site Requirements (Urine Instant Tests)

  • 1Single-stall restroom (or multi-stall with controls)
  • 2Bluing in toilet and tank
  • 3No accessible soap, cleaners, water source
  • 4Clean work surface for the device and form
  • 5Privacy — no observers

Site Requirements (Oral Instant Tests)

  • Private area, adequate lighting
  • Clean work surface
  • No food/drink/tobacco within reach

Security

  • Donor under continuous observation
  • Devices stored secure pre-collection
  • Results read within IFU window — no premature reads
  • Specimen retained for lab confirmation if non-negative
Section 4 of 12
Section 5 of 12

Devices & Supplies

Devices come in cup, cassette, or dip-card form. Each has the same workflow: specimen → wait → read. Choosing FUO vs CLIA-Waived is the most consequential supply decision.

Device Formats

FormatBest For
Integrated cupOnsite urine — donor provides, cup auto-reads
CassetteLab-style cassette read after dropper aliquot
Dip cardStrip dipped directly into specimen
Oral kitSaliva collection with absorbent pad → reader

Required Supplies

  • Test device — sealed, in date, FUO or CLIA-Waived per your program
  • Non-DOT CCF — employer or program-specific
  • Bluing (urine collections only)
  • Tamper-evident tape / seals
  • Gloves and PPE
  • IFU — printed copy at site
  • Lab shipping materials — for non-negative confirmation

Pre-Collection Checks

  • Device expiration date — current
  • Storage conditions met (temperature)
  • Lot number recorded
  • Package sealed and undamaged
Section 5 of 12
Section 6 of 12

The Non-DOT Custody & Control Form

Most non-DOT programs use a private (employer-branded or third-party) Custody and Control Form. It documents donor, collector, device, lot, expiration, result, and any non-negative referral.

Non-DOT CCF Structure

The form is not federally standardized for non-DOT. Most programs use a simplified version with:

  • Donor information
  • Employer information
  • Reason for test
  • Collection date / time
  • Device manufacturer, lot, expiration
  • Drug panel tested
  • Result (negative / non-negative)
  • Collector signature + donor signature
  • Lab name (for non-negative shipment)

Copy Distribution

Typical 3-part structure:

  • 1Copy 1 — collector retains (lab if non-negative)
  • 2Copy 2 — employer
  • 3Copy 3 — donor
Section 6 of 12
Section 7 of 12

Employer Information

For non-DOT instant testing, the employer or testing program sets the required information. Most programs mirror the DOT field set — donor, employer, reason, MRO referral pathway for non-negatives.

Required from Employer

  • Donor name + ID number
  • Employer name + contact
  • Reason for test (pre-employment, random, RS, post-accident)
  • Drug panel (5, 10, expanded)
  • Confirmation lab name + shipping address
  • MRO contact (if non-negatives are routed through MRO)
Tip: Some programs use a Designated Employer Representative (DER) like DOT — keep their contact information at the site.
Section 7 of 12
Section 8 of 12

Donor ID & Eligibility

Donor ID and eligibility for non-DOT instant testing follows the employer's policy. Photo ID is standard. Some programs require a brief medication disclosure window before collection.

Acceptable ID

  • Government photo ID
  • Employer photo badge
  • In-person identification by employer representative

Reasons to Defer or Reject

  • ! No ID and no employer present
  • ! Donor visibly intoxicated and unable to consent
  • ! Donor refuses signature on the chain of custody

Medication Disclosure

Many non-DOT programs use an MRO. Donors disclose after the test if non-negative — not before. Disclosing before can bias the collector. Document policy and follow it.

Section 8 of 12
Section 9 of 12

The Collection & Reading Results

The collection is straightforward — provide the specimen, set the device, wait 5 minutes, read. Misreading is the most common error. The two-lines = negative rule trips up new collectors every time.

The Collection Procedure

1

Prep the Site & Supplies

Device, form, bluing, tape, gloves all out.

2

Verify ID

Photo ID. Match the name on the form.

3

Explain Procedure

What you're testing, the wait time, the meaning of non-negative.

4

Complete Form

Donor and collector sections filled in. Device lot, expiration recorded.

5

Donor Empties Pockets & Washes Hands

Same as DOT — coats off, pockets emptied, hands washed.

6

Provide the Container / Open the Device

In donor's view.

7

Receive Specimen

Volume per device IFU. For urine: ≥ 30 mL typically.

8

Activate the Device

Per IFU. Note start time.

9

Wait the IFU Time

Typically 5 minutes. Don't read early. Don't read late (most IFUs invalidate after 10 minutes).

10

Read the Result

Within the IFU window.


Reading Results — The "Two Lines = Negative" Rule

For every drug panel on the device:

  • Control line (C) + Test line (T) BOTH presentNegative
  • Control line only — NO test lineNon-Negative (preliminary positive)
  • NO control lineInvalid (regardless of test line). Discard, repeat with a new device.
The test line on an immunoassay is INHIBITORY. When drugs are present, the test line fails to develop. Counterintuitive, but it's how the chemistry works.

Document the Result

  • Photograph the cassette / cup (optional but recommended)
  • Mark each panel's result on the form
  • Donor signs to acknowledge the read
  • Collector signs to certify
Section 9 of 12
Section 10 of 12

When Things Go Sideways

When the instant test reads non-negative — or when something goes wrong — you switch into lab confirmation mode. Send the same specimen to a lab for GC/MS or LC/MS confirmation. Never report a "positive" from an instant device.

Non-Negative Result

A non-negative is not a positive. It's a preliminary screening result that must be confirmed by a lab using GC/MS or LC/MS.

1

Don't Tell the Donor They Tested Positive

Say: "Your screening result is non-negative for X. We send the specimen to the lab for confirmation."

2

Seal & Ship the Specimen

Same specimen — pour into split bottles (A/B), seal, donor initials, complete chain of custody.

3

MRO Workflow

Lab → MRO → donor → employer. MRO contacts donor for medical explanation.

Invalid Result

  • ! No control line — device malfunction
  • Discard, document lot number
  • Repeat with a new device
  • Two invalids in a row → send specimen to lab and notify employer

Refusal Triggers

  • ! Refuses to provide specimen
  • ! Refuses to sign chain of custody
  • ! Leaves the site before collection complete
  • ! Caught adulterating or substituting

Out of Range Temperature

Same as DOT — if urine temp is < 90°F or > 100°F, suspect tampering. Document, send to lab if program permits, follow employer policy on observed re-collection.

Section 10 of 12
Section 11 of 12

Training & Documentation

Non-DOT collectors don't have a §40.33 requirement — but documented training, IFU compliance, and ongoing QC keep the program defensible. CLIA-Waived testing for clinical purposes requires a Certificate of Waiver.

Recommended Training Structure

  • aKnowledge of FUO vs CLIA-Waived; state law differences
  • bDevice-specific IFU training
  • c5+ supervised mock collections, including one non-negative
  • dResult-reading proficiency on photo / live samples
  • eAnnual refresher
  • fDocument everything — keep records of every collector and every training event

CLIA Certificate of Waiver (when applicable)

If your program uses CLIA-Waived devices for clinical purposes:

  • Apply with HHS CMS (Form CMS-116)
  • Pay biennial fee (~$180)
  • Follow manufacturer IFU exactly (no modifications)
  • Maintain QC records per device IFU
  • Some states require state-level CLIA in addition (CA, MD, PA, RI)

CLIA Waiver guide →

Recommended Retention

RecordPeriod
Negative CCFs1 year
Non-negative CCFs & lab confirmations5 years
Device lot / QC logs2 years
Collector training recordsWhile active + 2 years
Section 11 of 12
Section 12 of 12

Best Practices

Most instant test problems come from misreading lines, expired devices, or skipping the confirmation step on a non-negative. Build a checklist and run it every time.

Top 10 Instant Test Mistakes

  • 1Reading the test before the 5-minute window
  • 2Reading past the 10-minute window (invalid)
  • 3Calling a non-negative "positive" to the donor
  • 4Using an expired device
  • 5Forgetting to record device lot number
  • 6Skipping the chain-of-custody form for non-negatives
  • 7Misreading the control vs test line (faint test line = still negative)
  • 8Forgetting bluing → specimen dilution
  • 9Doing a CLIA-Waived clinical test without a Certificate of Waiver
  • 10No retention policy for QC and CCFs

Best Practices Checklist

  • Always confirm device type (FUO vs CLIA-Waived) and program purpose
  • IFU printed at the site — read it before each shift
  • Record lot + expiration on every form
  • Stay within the IFU read window — every time
  • Non-negative = lab confirmation, MRO review, donor explanation. Never "positive."
  • Document refusals and incidents with photos when possible
You've completed the Instant Drug Testing Module!
Need help setting up an instant testing program? Contact us about training and program design.
Enroll & Train with Us →
Section 12 of 12